Press Resease

Prenatal DNA Sequencing Market - Global Industry Analysis

Prenatal DNA Sequencing Market By Application (Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS, Cancer, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 27-Aug-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-4630 Status : Published

Global prenatal DNA sequencing market expected to generate around USD 2,605 million by 2025, growing at a CAGR of around 13.37% between 2019 and 2025. DNA sequencing is defined as a process that is used to determine the order or sequence of nucleotides within DNA particles.

Description

The report covers a forecast and an analysis of the prenatal DNA sequencing market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the prenatal DNA sequencing market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the prenatal DNA sequencing market on a global and regional level.

In order to give the users of this report a comprehensive view of the prenatal DNA sequencing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Prenatal DNA Sequencing Market

The report provides company market share analysis to give a broader overview of the key players in the prenatal DNA sequencing market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the prenatal DNA sequencing market by segmenting it based on application and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players in the prenatal DNA sequencing market are Agilent Technologies, F. Hoffmann-La Roche, Laboratory Corporation of America, Natera, Genomic Health, Myriad Genetics, Invitae, BGI, and Illumina.

This report segments the global prenatal DNA sequencing market into:

Global Prenatal DNA Sequencing Market: By Application

  • Hemophilia
  • DiGeorge Syndrome
  • Cystic Fibrosis
  • Down Syndrome
  • Autism
  • Cancer
  • AIDS
  • Others

Global Prenatal DNA Sequencing Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Prenatal DNA Sequencing Market Revenue, 2016-2025 (USD Million)
    • 2.2. Global Prenatal DNA Sequencing Market: Snapshot
  •  
  • Chapter 3. Prenatal DNA Sequencing Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Prenatal DNA Sequencing Market drivers: Impact analysis
      • 3.2.2. Rising incidences of various chronic diseases like cancer and AIDS
      • 3.2.3. Increase in R&D investment for preventing chronic diseases
      • 3.2.4. Growing technological improvements in DNA sequencing
    • 3.3. Market restraints
      • 3.3.1. The high cost of sequencing
    • 3.4. Opportunities
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Application
      • 3.6.2. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Prenatal DNA Sequencing Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Prenatal DNA Sequencing Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Application Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Prenatal DNA Sequencing Market - Application Analysis
    • 5.1. Global Prenatal DNA Sequencing Market: Application overview
      • 5.1.1. Global Prenatal DNA Sequencing Market share, by Application, 2018 and 2025
    • 5.2. Hemophilia
      • 5.2.1. Global Prenatal DNA Sequencing Market for Hemophilia, 2016-2025 (USD Million)
    • 5.3. Down Syndrome
      • 5.3.1. Global Prenatal DNA Sequencing Market for Down Syndrome, 2016-2025 (USD Million)
    • 5.4. Cystic Fibrosis
      • 5.4.1. Global Prenatal DNA Sequencing Market for Cystic Fibrosis, 2016-2025 (USD Million)
    • 5.5. Autism
      • 5.5.1. Global Prenatal DNA Sequencing Market for Autism, 2016-2025 (USD Million)
    • 5.6. DiGeorge Syndrome
      • 5.6.1. Global Prenatal DNA Sequencing Market for DiGeorge Syndrome, 2016-2025 (USD Million)
    • 5.7. AIDS
      • 5.7.1. Global Prenatal DNA Sequencing Market for AIDS, 2016-2025 (USD Million)
    • 5.8. Cancer
      • 5.8.1. Global Prenatal DNA Sequencing Market for Cancer, 2016-2025 (USD Million)
    • 5.9. Others
      • 5.9.1. Global Prenatal DNA Sequencing Market for Others, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Prenatal DNA Sequencing Market - Regional Analysis
    • 6.1. Global Prenatal DNA Sequencing Market: Regional overview
      • 6.1.1. Global Prenatal DNA Sequencing Market share, by region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.2.2. The U.S.
        • 6.2.2.1. The U.S. Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.2.3. Rest of North America
        • 6.2.3.1. Rest of North America Prenatal DNA Sequencing Market Revenue, by Application,2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.2. Germany
        • 6.3.2.1. Germany Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.3. The U.K.
        • 6.3.3.1. U.K. Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.3.5. Rest of Europe
        • 6.3.5.1. Rest of Europe Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.2. China
        • 6.4.2.1. China Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.3. Japan
        • 6.4.3.1. Japan Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.4. India
        • 6.4.4.1. India Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.4.5. Rest of Asia Pacific
        • 6.4.5.1. Rest of Asia Pacific Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.5.2. Brazil
        • 6.5.2.1. Brazil Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
      • 6.5.3. Rest of Latin America
        • 6.5.3.1. Rest of Latin America Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa Prenatal DNA Sequencing Market Revenue, by Application, 2016-2025 (USD Million)
  •  
  • Chapter 7. Company Profile
    • 7.1. Agilent Technologies
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Application Portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. F. Hoffmann-La Roche
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Application Portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. Laboratory Corporation of America
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Application Portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Natera
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Application Portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Genomic Health
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Application Portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. Myriad Genetics
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Application Portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. Invitae
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Application Portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. BGI
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Application Portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments
    • 7.9. Illumina
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Application Portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments

Methodology

Free Analysis

DNA sequencing is defined as a process that is used to determine the order or sequence of nucleotides within DNA particles. Prenatal DNA sequencing is a DNA sequencing method extracted from an expectant women’s blood to disclose the full genetic code of a fetus. It is used to structure the whole genome of an unborn baby, which helps in effectively detecting the diseases cystic fibrosis, down syndrome, cancer, etc. The prenatal DNA sequencing technology has huge acceptance across the globe, due to its various applications. This technology has a huge impact on the public healthcare sector. Various companies and laboratories have introduced diagnostic tests based on sequencing technology. The demand for Prenatal DNA sequencing technology is increasing worldwide, due to its wide and effective use. Despite its wide application and usage, the DNA sequencing instruments are facing challenges in terms of high cost as many small laboratories can’t afford the prenatal DNA sequencing instruments.

There are various factors driving the prenatal DNA sequencing market globally. The demand for prenatal DNA sequencing technology is increasing rapidly in the global market, due to the introduction of new technologies of DNA sequencing process and increasing incidences of chronic diseases like cancer and AIDS, among others. In addition, increasing R&D investments for preventing chronic diseases also contribute to the prenatal DNA sequencing market globally. However, the high cost of DNA sequencing may be a major restraining factor affecting the prenatal DNA sequencing market development in the years ahead. Nevertheless, the increasing number of laboratories and various diagnostic firms provide ample opportunity for the prenatal DNA sequencing market growth.

Global Prenatal DNA Sequencing Market

The prenatal DNA sequencing market is segmented on the basis of application and region. The application segment is divided into down syndrome, hemophilia, cystic fibrosis, AIDS, DiGeorge syndrome, autism, cancer, and others. Genetic diseases, such as AIDS, hemophilia, and down syndrome, holds the largest market share and are expected to dominate the prenatal DNA sequencing market in terms of revenue in the years ahead, owing to the increasing cases of AIDS, cancer, and other chronic diseases.

North America dominates the market due to the rising number of genetic diseases that require an increased number of hospitals for treatment. The U.S is the main market players, due to the availability of advanced healthcare infrastructure, technological improvements in DNA sequencing, and growing R&D investment in prenatal DNA sequencing technology. Europe held the second spot of the prenatal DNA sequencing market share in 2018. The Asia Pacific prenatal DNA sequencing market is the fastest-growing region that shall register the highest CAGR over the forecast time period. The key factors driving this regional market are growing population base, rising number of patients suffering from cancer, AIDS, etc., and increasing healthcare expenditure. The Middle East and Africa prenatal DNA sequencing market will show sluggish growth in the future, owing to the lack of funding required for the implementation of prenatal DNA sequencing technique due to the high installation costs.

Some major players in the prenatal DNA sequencing market are Agilent Technologies, F. Hoffmann-La Roche, Laboratory Corporation of America, Natera, Genomic Health, Myriad Genetics, Invitae, BGI, and Illumina

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social